• 
  Xavier Montagutelli, Matthieu Prot, Laurine Levillayer, Eduard Baquero Salazar, Grégory Jouvion, et al.. Variants with the N501Y mutation extend SARS-CoV-2 host range to mice, with contact transmission. 2023. ⟨pasteur-04168583⟩
• 
  Camille Chauvin, Laurine Levillayer, Mathilde Roumier, Hubert Nielly, Claude Roth, et al.. Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants. iScience, 2023, 26 (3), pp.106124. ⟨10.1016/j.isci.2023.106124⟩. ⟨hal-04090334⟩
• 
  Arianna Ceruti, Ndongo Dia, Adeleye Solomon Bakarey, Judah Ssekitoleko, Soa Fy Andriamandimby, et al.. A multi-country phase 2 study to evaluate the suitcase lab for rapid detection of SARS-CoV-2 in seven Sub-Saharan African countries: Lessons from the field. Journal of Clinical Virology, 2023, 162, pp.105422. ⟨10.1016/j.jcv.2023.105422⟩. ⟨pasteur-04096796⟩
• 
  Xavier Montagutelli, Matthieu Prot, Grégory Jouvion, Laurine Levillayer, Laurine Conquet, et al.. A mouse-adapted SARS-CoV-2 strain replicating in standard laboratory mice. 2023. ⟨pasteur-04073355⟩
• 
  Marion Plaze, David Attali, Matthieu Prot, Anne-Cécile Petit, Michael Blatzer, et al.. Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine. International Journal of Antimicrobial Agents, 2021, 57 (3), pp.106274. ⟨10.1016/j.ijantimicag.2020.106274⟩. ⟨pasteur-03277133⟩

64

11